The RASSF1A Isoform of RASSF1 Promotes Microtubule Stability and Suppresses Tumorigenesis

REFERENCES

• Bhilwade, H. N., R. C. Chaubey, and P. S. Chauhan. 2004. Gamma ray induced bone marrow micronucleated erythrocytes in seven strains of mouse. Mutat. Res. 560:19–26.
   PubMed Web of Science ®Google Scholar
• Burbee, D. G., E. Forgacs, S. Zochbauer-Muller, L. Shivakumar, K. Fong, B. Gao, D. Randle, M. Kondo, A. Virmani, S. Bader, Y. Sekido, F. Latif, S. Milchgrub, S. Toyooka, A. F. Gazdar, M. I. Lerman, E. Zabarovsky, M. White, and J. D. Minna. 2001. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. 93:691–699.
   PubMed Web of Science ®Google Scholar
• Byun, D. S., M. G. Lee, K. S. Chae, B. G. Ryu, and S. G. Chi. 2001. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res. 61:7034–7038.
   PubMed Web of Science ®Google Scholar
• Crosio, C., G. M. Fimia, R. Loury, M. Kimura, Y. Okano, H. Zhou, S. Sen, C. D. Allis, and P. Sassone-Corsi. 2002. Mitotic phosphorylation of histone H3: spatiotemporal regulation by mammalian Aurora kinases. Mol. Cell. Biol. 22:874–885.
   PubMed Web of Science ®Google Scholar
• Dallol, A., A. Agathanggelou, S. L. Fenton, J. Ahmed-Choudhury, L. Hesson, M. D. Vos, G. J. Clark, J. Downward, E. R. Maher, and F. Latif. 2004. RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res. 64:4112–4116.
   PubMedGoogle Scholar
• Dammann, R., C. Li, J. H. Yoon, P. L. Chin, S. Bates, and G. P. Pfeifer. 2000. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet. 25:315–319.
   PubMed Web of Science ®Google Scholar
• Dammann, R., U. Schagdarsurengin, M. Stunnikova, M. Rastetter, C. Seidel, L. Liu, S. Tommasi, and G. P. Pfeifer. 2003. Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. Histol. Histopathol. 18:665–677.
   PubMedGoogle Scholar
• Dikovskaya, D., I. P. Newton, and I. S. Nathke. 2004. The adenomatous polyposis coli protein is required for the formation of robust spindles formed in CSF Xenopus extracts. Mol. Biol. Cell 15:2978–2991.
   PubMed Web of Science ®Google Scholar
• Dreijerink, K., E. Braga, I. Kuzmin, L. Geil, F. M. Duh, D. Angeloni, B. Zbar, M. I. Lerman, E. J. Stanbridge, J. D. Minna, A. Protopopov, J. Li, V. Kashuba, G. Klein, and E. R. Zabarovsky. 2001. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc. Natl. Acad. Sci. USA 98:7504–7509.
   PubMedGoogle Scholar
• Heddle, J. A. 1973. A rapid in vivo test for chromosomal damage. Mutat. Res. 18:187–190.
   PubMed Web of Science ®Google Scholar
• Hung, J., Y. Kishimoto, K. Sugio, A. Virmani, D. D. McIntire, J. D. Minna, and A. F. Gazdar. 1995. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273:558–563.
   PubMed Web of Science ®Google Scholar
• Kang, G. H., S. Lee, J. S. Kim, and H. Y. Jung. 2003. Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab. Investig. 83:519–526.
   PubMed Web of Science ®Google Scholar
• Lee, S., H. J. Lee, J. H. Kim, H. S. Lee, J. J. Jang, and G. H. Kang. 2003. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am. J. Pathol. 163:1371–1378.
   PubMedGoogle Scholar
• Lerman, M. I., and J. D. Minna. 2000. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung CancerChromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 60:6116–6133.
   PubMed Web of Science ®Google Scholar
• Li, J., F. Wang, A. Protopopov, A. Malyukova, V. Kashuba, J. D. Minna, M. I. Lerman, G. Klein, and E. Zabarovsky. 2004. Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene. Oncogene 23:5941–5949.
   PubMedGoogle Scholar
• Liu, L., S. Tommasi, D. H. Lee, R. Dammann, and G. P. Pfeifer. 2003. Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene 22:8125–8136.
   PubMedGoogle Scholar
• Maruyama, R., S. Toyooka, K. O. Toyooka, K. Harada, A. K. Virmani, S. Zochbauer-Muller, A. J. Farinas, F. Vakar-Lopez, J. D. Minna, A. Sagalowsky, B. Czerniak, and A. F. Gazdar. 2001. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res. 61:8659–8663.
   PubMed Web of Science ®Google Scholar
• McMahon, A. P., and A. Bradley. 1990. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 62:1073–1085.
   PubMed Web of Science ®Google Scholar
• Munemitsu, S., B. Souza, O. Muller, I. Albert, B. Rubinfeld, and P. Polakis. 1994. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res. 54:3676–3681.
   PubMed Web of Science ®Google Scholar
• Nusse, M., B. M. Miller, S. Viaggi, and J. Grawe. 1996. Analysis of the DNA content distribution of micronuclei using flow sorting and fluorescent in situ hybridization with a centromeric DNA probe. Mutagenesis 11:405–413.
   PubMedGoogle Scholar
• Ortiz-Vega, S., A. Khokhlatchev, M. Nedwidek, X. F. Zhang, R. Dammann, G. P. Pfeifer, and J. Avruch. 2002. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene 21:1381–1390.
   PubMedGoogle Scholar
• Pfeifer, F. P., J. H. Yoon, L. Liu, S. Tommasi, S. P. Wilczynski, and R. Dammann. 2002. Methylation of the RASFF1A gene in human cancers. Biol. Chem. 383:907–914.
   PubMed Web of Science ®Google Scholar
• Pizzi, S., C. Azzoni, D. Bassi, L. Bottarelli, M. Milione, and C. Bordi. 2003. Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract. Cancer 98:1273–1282.
   PubMedGoogle Scholar
• Ramirez-Solis, R., P. Liu, and A. Bradley. 1995. Chromosome engineering in mice. Nature 378:720–724.
   PubMed Web of Science ®Google Scholar
• Rong, R., W. Jin, J. Zhang, M. S. Sheikh, and Y. Huang. 2004. Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrest. Oncogene 23:8216–8230.
   PubMedGoogle Scholar
• Sakamoto, N., T. Terai, Y. Ajioka, S. Abe, O. Kobayasi, S. Hirai, O. Hino, H. Watanabe, N. Sato, T. Shimoda, and H. Fujii. 2003. Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors. Oncogene 23:8900–8907.
   Google Scholar
• Schaft, J., R. Ashery-Padan, F. van der Hoeven, P. Gruss, and A. F. Stewart. 2001. Efficient FLP recombination in mouse ES cells and oocytes. Genesis 31:6–10.
   PubMedGoogle Scholar
• Schagdarsurengin, U., L. Wilkens, D. Steinemann, P. Flemming, H. H. Kreipe, G. P. Pfeifer, B. Schlegelberger, and R. Dammann. 2003. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene 22:1866–1871.
   PubMedGoogle Scholar
• Sharan, S. K., M. Morimatsu, U. Albrecht, D. S. Lim, E. Regel, C. Dinh, A. Sands, G. Eichele, P. Hasty, and A. Bradley. 1997. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386:804–810.
   PubMed Web of Science ®Google Scholar
• Shima, N., S. A. Hartford, T. Duffy, L. A. Wilson, K. J. Schimenti, and J. C. Schimenti. 2003. Phenotype-based identification of mouse chromosome instability mutants. Genetics 163:1031–1040.
   PubMedGoogle Scholar
• Shing, D. C., C. A. Morley-Jacob, I. Roberts, E. Nacheva, and N. Coleman. 2002. Ewing's tumour: novel recurrent chromosomal abnormalities demonstrated by molecular cytogenetic analysis of seven cell lines and one primary culture. Cytogenet. Genome Res. 97:20–27.
   PubMedGoogle Scholar
• Shivakumar, L., J. Minna, T. Sakamaki, R. Pestell, and M. A. White. 2002. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol. Cell. Biol. 22:4309–4318.
   PubMed Web of Science ®Google Scholar
• Song, M. S., S. J. Song, N. G. Ayad, J. S. Chang, J. H. Lee, H. K. Hong, H. Lee, N. Choi, J. Kim, H. Kim, J. W. Kim, E. J. Choi, M. W. Kirschner, and D. S. Lim. 2004. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat. Cell Biol. 6:129–137.
   PubMed Web of Science ®Google Scholar
• Su, T. T., and J. Stumpff. 9 March 2004, posting date. Promiscuity rules? The dispensability of cyclin E and Cdk2. Sci. STKE 224: pe11. [Online.] http://stke.sciencemag.org/cgi/content/full/OC_sigtrans;stke.2242004pe11.
   Google Scholar
• To, K. F., W. K. Leung, T. L. Lee, J. Yu, J. H. Tong, M. W. Chan, E. K. Ng, S. C. Chung, and J. J. Sung. 2002. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int. J. Cancer 102:623–628.
   PubMed Web of Science ®Google Scholar
• van der Weyden, L., D. J. Adams, L. W. Harris, D. Tannahill, M. J. Arends, and A. Bradley. 2005. Null and conditional Semaphorin 3B alleles using a flexible puroΔtk LoxP/FRT vector. Genesis 41:171–178.
   PubMedGoogle Scholar
• van Engeland, M., G. M. Roemen, M. Brink, M. M. Pachen, M. P. Weijenberg, A. P. de Bruine, J. W. Arends, P. A. van den Brandt, A. F. de Goeij, and J. G. Herman. 2002. K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene 21:3792–3795.
   PubMed Web of Science ®Google Scholar
• Vos, M. D., C. A. Ellis, A. Bell, M. J. Birrer, and G. J. Clark. 2000. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J. Biol. Chem. 275:35669–35672.
   PubMed Web of Science ®Google Scholar
• Vos, M. D., A. Martinez, C. Elam, A. Dallol, B. J. Taylor, F. Latif, and G. J. Clark. 2004. A role for the RASSF1A tumour suppressor in the regulation of tubulin depolymerisation and genomic instability. Cancer Res. 64:4244–4250.
   PubMedGoogle Scholar
• Wagner, K. J., W. N. Cooper, R. G. Grundy, G. Caldwell, C. Jones, R. B. Wadey, D. Morton, P. N. Schofield, W. Reik, F. Latif, and E. R. Maher. 2002. Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer. Oncogene 21:7277–7282.
   PubMedGoogle Scholar
• Wang, J., J. J. Lee, L. Wang, D. D. Liu, C. Lu, Y. H. Fan, W. K. Hong, and L. Mao. 2004. Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer. Clin. Cancer Res. 10:6119–6125.
   PubMed Web of Science ®Google Scholar
• Wistuba, I. I., C. Behrens, A. K. Virmani, G. Mele, S. Milchgrub, L. Girard, J. W. Fondon, H. R. Garner, B. McKay, F. Latif, M. I. Lerman, S. Lam, A. F. Gazdar, and J. D. Minna. 2000. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 60:1949–1960.
   PubMed Web of Science ®Google Scholar
• Yang, Q., P. Zage, D. Kagan, Y. Tian, R. Seshadri, H. R. Salwen, S. Liu, A. Chlenski, and S. L. Cohn. 2004. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma. Clin. Cancer Res. 10:8493–8500.
   PubMedGoogle Scholar
• Zhong, S., W. Yeo, M. W. Tang, N. Wong, P. B. Lai, and P. J. Johnson. 2003. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Clin. Cancer Res. 9:3376–3382.
   PubMedGoogle Scholar
• Zumbrunn, J., K. Kinoshita, A. A. Hyman, and I. S. Näthke. 2001. Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK-3β phosphorylation. Curr. Biol. 11:44–49.
   PubMed Web of Science ®Google Scholar